Tricine co-ligand improved the efficacy of 99mTc-HYNIC-(Ser)3-J18 peptide for targeting and imaging of non-small-cell lung cancer - 11/06/18
pages | 7 |
Iconographies | 5 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
Highlights |
• | 99mTc-(tricine)-HYNIC-(Ser)3-J18 peptide was prepared at high radiochemical purity at room temperature. |
• | This radioconjugate exhibited high stability in normal saline and human serum. |
• | This radiolabeled peptide specifically bond to A-549 cells. |
• | The tumor–to–muscle ratio was 5.6 at 2 h after injection of radiolabeled peptide. |
• | The A-549 tumor could be seen clearly at 2 h after injection of radiolabeled peptide. |
Abstract |
The early diagnosis of non-small cell lung cancer (NSCLC) is important for increasing survival rate and improving quality life of patients. The aim of this study was to investigate 99m Tc-(tricine)-HYNIC-(Ser)3-J18 for targeting and imaging of NSCLC in A-549 xenografted nude mice. The (Ser)3-J18 peptide was conjugated with HYNIC and labeled with 99m Tc using tricine as a co-ligand. The radiolabeled peptide was evaluated for its radiochemical purity, stability, receptor binding and internalization in vitro. The future experiments were performed for tumor targeting and imaging in A-549 tumor-bearing mice. 99m Tc-(tricine)-HYNIC-(Ser)3-J18 was obtained at high labeling efficiency at room temperature and favorable stability in saline and human plasma. At the cellular level, the radiolabeled peptide specifically bond to A-549 cells with a KD 4.1 ± 1.3 nM. Biodistribution study revealed tumor to blood and tumor to muscle ratios were about 3.12 and 5.63 respectively after 2 h injection of radiolabeled peptide. These ratios were significantly decreased by co-injection of excess non-labeled peptide in mice. This radiolabeled peptide selectively targeted to NSCLC tumor and exhibited a high target uptake combined with acceptable low background activity for tumor imaging in mice. The results of this study and its comparison with another study showed that 99m Tc-(tricine)-HYNIC-(Ser)3-J18 is better than previously reported radiolabeled peptide as 99m Tc-(EDDA/tricine)-HYNIC-(Ser)3-J18 for NSCLC targeting and imaging.
Le texte complet de cet article est disponible en PDF.Abbreviations : 99mTc, HYNIC, EDDA, GSG, Tricine
Keywords : NSCLC, J18, Tricine, Peptide, HYNIC, 99mTc, Radiolabeled
Plan
Vol 104
P. 325-331 - août 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?